Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Farzan Solimani

Showing results (31-40 of 62) with videos related to

Pageof 7
Sort By:
Frontiers in Medicine|February 23, 2023
The cytokine milieu of bullous pemphigoid: Current and novel therapeutic targetsRoberto Maglie, Farzan Solimani, Dario Didona, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 2, 2025
Treatment of juvenile bullous pemphigoid with lebrikizumabMarcel Wittenberg, Farzan Solimani, Amrei Dilling, et al.
International Journal of Dermatology|February 11, 2026
Use of Lebrikizumab in Treatment-Refractory Bullous Pemphigoid: Two ReportsChristoph Zeyen, Farzan Solimani, Meslina Almaci, et al.
Frontiers in Medicine|October 21, 2022
Therapeutic strategies for oral lichen planus: State of the art and new insightsDario Didona, Raffaele Dante Caposiena Caro, Antonio Manuel Sequeira Santos, et al.
European Journal of Immunology|February 22, 2023
Interleukin-21 in autoimmune and inflammatory skin diseasesAlberto Mesas-Fernández, Euna Bodner, Franz Joachim Hilke, et al.
Clinical and Experimental Dermatology|September 27, 2023
Rapid and sustained response to tralokinumab in a patient with severe bullous pemphigoid and end-stage kidney diseaseRoberto Maglie, Maria Efenesia Baffa, Stefano Senatore, et al.
The British Journal of Dermatology|January 29, 2025
Off-label use of tralokinumab in the treatment of bullous pemphigoid: a case seriesRoberto Maglie, Dario Didona, Farzan Solimani, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 22, 2025
A febrile papulovesicular rash in a patient with pyoderma gangrenosumAnika Rajput Khokhar, Charlotte S Wilm, Katharina Meier, et al.
Frontiers in Immunology|October 7, 2022
Detection of rare autoreactive T cell subsets in patients with pemphigus vulgarisAlexandra Polakova, Leonie Kauter, Adina Ismagambetova, et al.
Experimental Dermatology|April 17, 2024
TYK2 inhibition with deucravacitinib ameliorates erosive oral lichen planusKim Natalie Stolte, Alberto Mesas-Fernández, Katharina Meier, et al.
Pageof 7

Showing results (31-40 of 62) with videos related to

Sort By:
Pageof 7
Frontiers in Medicine|February 23, 2023
The cytokine milieu of bullous pemphigoid: Current and novel therapeutic targetsRoberto Maglie, Farzan Solimani, Dario Didona, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 2, 2025
Treatment of juvenile bullous pemphigoid with lebrikizumabMarcel Wittenberg, Farzan Solimani, Amrei Dilling, et al.
International Journal of Dermatology|February 11, 2026
Use of Lebrikizumab in Treatment-Refractory Bullous Pemphigoid: Two ReportsChristoph Zeyen, Farzan Solimani, Meslina Almaci, et al.
Frontiers in Medicine|October 21, 2022
Therapeutic strategies for oral lichen planus: State of the art and new insightsDario Didona, Raffaele Dante Caposiena Caro, Antonio Manuel Sequeira Santos, et al.
European Journal of Immunology|February 22, 2023
Interleukin-21 in autoimmune and inflammatory skin diseasesAlberto Mesas-Fernández, Euna Bodner, Franz Joachim Hilke, et al.
Clinical and Experimental Dermatology|September 27, 2023
Rapid and sustained response to tralokinumab in a patient with severe bullous pemphigoid and end-stage kidney diseaseRoberto Maglie, Maria Efenesia Baffa, Stefano Senatore, et al.
The British Journal of Dermatology|January 29, 2025
Off-label use of tralokinumab in the treatment of bullous pemphigoid: a case seriesRoberto Maglie, Dario Didona, Farzan Solimani, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 22, 2025
A febrile papulovesicular rash in a patient with pyoderma gangrenosumAnika Rajput Khokhar, Charlotte S Wilm, Katharina Meier, et al.
Frontiers in Immunology|October 7, 2022
Detection of rare autoreactive T cell subsets in patients with pemphigus vulgarisAlexandra Polakova, Leonie Kauter, Adina Ismagambetova, et al.
Experimental Dermatology|April 17, 2024
TYK2 inhibition with deucravacitinib ameliorates erosive oral lichen planusKim Natalie Stolte, Alberto Mesas-Fernández, Katharina Meier, et al.
Pageof 7